Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfenex Inc (PFNX)

Pfenex Inc (PFNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pfenex Inc 10790 ROSELLE STREET SAN DIEGO CA 92121 USA

P: 858-352-4400 F: 858-352-4602

Description:

Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform to build a pipeline of product candidates and preclinical products under development including other biosimilars, as well as vaccines, generics and next generation biologics. Pfenex Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 336,399
Shares Outstanding, K 31,676
Annual Sales, $ 14,860 K
Annual Net Income, $ -39,590 K
Last Quarter Sales, $ 15,250 K
Last Quarter Net Income, $ 3,080 K
60-Month Beta 2.32
% of Insider Shareholders 3.10%
% of Institutional Shareholders 77.97%
Float, K 30,694
% Float 96.90%

Growth:

1-Year Return 195.82%
3-Year Return 10.74%
5-Year Return 64.65%
5-Year Revenue Growth 24.77%
5-Year Earnings Growth -268.42%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/07/19
Earnings Per Share ttm -0.49
EPS Growth vs. Prev Qtr 137.50%
EPS Growth vs. Prev Year 126.47%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

PFNX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.38
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -26.46
Return-on-Assets (Before Tax) -20.96
Profit Margin % -266.42
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 22.64
Price/Cash Flow N/A
Price/Book 6.01
Book Value/Share 1.77
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar